Pharmacokinetic behavior of micafungin in rats with carbon tetrachloride-induced acute hepatic failure

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 3, 2005, Pages 556-559

  Konishi, Hiroki ^a   Sudo, Masatomo ^a,b   Sumi, Masaki ^a   Morii, Hiroaki ^a   Minouchi, Tokuzo ^a   Aimoto, Tachio ^b   Yamaji, Akira ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

Author keywords

Acute hepatic failure rat; Carbon tetrachloride; Elimination clearance; Micafungin pharmacokinetics; Tissue distribution

Indexed keywords

BILIRUBIN; CARBON TETRACHLORIDE; CREATININE; CYCLOSPORIN A; MICAFUNGIN; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TISSUE LEVEL; LIVER FAILURE; MALE; NONHUMAN; RAT; STEADY STATE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CARBON TETRACHLORIDE; INJECTIONS, INTRAVENOUS; LIPOPROTEINS; LIVER FAILURE, ACUTE; MALE; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 21144437887     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.556     Document Type: Article

References (24)

1. Kurtz M. B., Heath I. B., Marrinan J., Dreikorn S., Onishi J., Douglas C., Antimicrob. Agents Chemother., 38, 1480-1489 (1994).
2. Tomishima M., Ohki H., Yamada A., Takasugi H., Maki K., Tawara S., Tanaka H., J. Antibiot., 52, 674-676 (1999).
3. Hatano K., Morishita Y., Nakai T., Ikeda F., J. Antibiot., 55, 219-222 (2002).
4. Ikeda F., Folia Pharmacol. Jpn., 122, 339-344 (2003).
5. Jarvis B., Figgitt D. P., Scott L. J., Drugs, 64, 969-982 (2004).
6. Kaneko H., Yamato Y., Teramura Y., Fujiwara T., Suzuki A., Kawamura A., Terakawa M., Kagayama A., Jpn. J. Chemother., 50 (Suppl. 1), 88-93 (2002).
7. Yamato Y., Kaneko H., Yamasaki S., Fujiwara T., Katashima M., Kawamura A., Terakawa M., Kagayama A., Jpn. J. Chemother., 50 (Suppl. 1), 80-87 (2002).
8. Yamato Y., Kaneko H., Tanimoto K., Katashima M., Ishibashi K., Kawamura A., Terakawa M., Kagayama A., Jpn. J. Chemother., 50 (Suppl. 1), 68-73 (2002).
9. Tabata K., Yamaoka K., Kaibara A., Suzuki S., Terakawa M., Hata T., Xenobio. Metabol. Dispos., 14, 286-293 (1999).
10. Terblanche J., Hickman R., Dig. Dis. Sci., 36, 770-774 (1991).
11. Shibata N., Shimakawa H., Minouchi T., Yamaji A., Biol. Pharm. Bull., 16, 1130-1135 (1993).
12. Fukuyama T., Yamaoka K., Tabata K., Nakagawa T., Biol. Pharm. Bull., 18, 251-255 (1995).
13. Ogiso T., Kitagawa T., Iwaki M., Tanino T., Biol. Pharm. Bull., 20, 405-410 (1997).
14. Sasa H., Hashimoto Y., Shimizu T., Inui K., Biol. Pharm. Bull., 21, 610-614 (1998).
15. Naora K., Ichikawa N., Hirano H., Iwamoto K., J. Pharm. Pharmacol., 51, 609-616 (1999).
16. Mukai T., Mera K., Nishida K., Nakashima M., Sasaki H., Sakaeda T., Nakamura J., Biol. Pharm. Bull., 25, 1494-1497 (2002).
17. Taira Z., Yabe K., Hamaguchi Y., Hirayama K., Kishimoto M., Ishida S., Ueda Y., Food Chem. Toxicol., 42, 803-807 (2004).
18. Mukai T., Mera K., Nishida K., Nakashima M., Sasaki H., Nakamura J., Biol. Pharm. Bull., 27, 595-597 (2004).
19. Azri S., Mata H. P., Gandolfi A. J., Brendel K., Adv. Exp. Med. Biol., 283, 669-674 (1991).
20. Kaneko H., Yamato Y., Hashimoto T., Ishii I., Shiraga T., Kawamura A., Terakawa M., Kagayama A., Jpn. J. Chemother., 50 (Suppl. 1), 94-103 (2002).
21. Maurer G., Loosli H. R., Schreier E., Keller B., Drug Metab. Dispos., 12, 120-126 (1984).
22. Niwa T., Yokota Y., Tokunaga A., Yamato Y., Kagayama A., Fujiwara T., Hatakeyama J., Anezaki M., Ohtsuka Y., Takagi A., Biol. Pharm. Bull., 27, 1154-1156 (2004).
23. Fujita H., Okamoto M., Takao A., Mase H., Kojima H., Jpn. J. Cancer Chemother., 21, 659-664 (1994).
24. Abraham P., Wilfred G., Cathrine S. P., Clin. Chim. Acta, 289, 177-179 (1999).